STAT - Reporting from the frontiers of health and medicine

Health Tech

In the Lab

Health

By Lauran Neergaard — Associated Press

First Opinion For prenatal care, more doesn’t necessarily mean better
Pharmalot ‘For good rather than evil’: Mark Cuban and an employer’s coalition to launch new PBMs to lower drug costs
Biotech Eight years after a landmark Supreme Court ruling on DNA ownership, its ramifications are becoming clearer
First Opinion Fake, substandard vaccines and medicines spell trouble for controlling Covid-19
First Opinion Don’t give Covid-19 long-haulers the silent treatment

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

FDA warns a hospital and two physicians for putting patients at ‘significantly increased’ risk in trials
Pharmalittle: Most pharma money went to Dems holding up drug-pricing reform; European officials raid pharma animal health company
Up and down the ladder: the latest comings and goings

A STAT Investigation

A STAT Investigation

Health

A STAT Investigation

Health

Special Report

Health Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Health Deadly infection linked to contaminated room spray sold at Walmart
Health The Covid-19 Tracker
Health FDA scientists say benefits of Pfizer Covid-19 vaccine ‘clearly outweigh’ the risks for children ages 5 to 11
Health Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate
Pharmalot ‘For good rather than evil’: Mark Cuban and an employer’s coalition to launch new PBMs to lower drug costs
Health Tech The stirrings of revolt: Hospitals nationwide are sidestepping health record giants to better harness patient data
First Opinion Fake, substandard vaccines and medicines spell trouble for controlling Covid-19